Alloy is Building the World's First Fully Integrated Product Development
Organization - Read the full article
A Tale of Two (or More) Targets: What We’ve Learned Building Multispecifics for Our Partners
Alloy’s perspective on the multispecific engineering problem Most protein engineers designing multispecifics today learned the craft on monoclonals, and some of the discovery and development infrastructure followed the same path. That’s a reasonable starting point. It’s also where a lot of the late-stage surprises come from. Multispecific antibodies aren’t just harder monoclonals. They’re a fundamentally […]